chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She reports receiving Covid-19 vaccine on 1/9/2021 on left arm at "Infusion Center". She states that "immediately" after she received vaccine she felt "tongue tingling". About 10 min later she felt "lip tingling" and started to develop "large red bump" at injection site. She advised nurse observing patients and physician on site was advised. Pt reports she was administered EPI and Benadryl IM and "felt better almost immediately". Pt states "tingling" resolved within the hour and she felt "scalded tongue" for about 24 hrs. Large local reaction slowly resolved over a 3 day period. She denies any visible skin rash / hives or AE. No throat sx. No resp sx. No GI sx. Pt denies a hx of adverse reactions to any injected medication or to any vaccine in the past. She reports that 30+ years ago she had "facial swelling" on day 10/10 of Dirucef which she was taking orally for sinus infection. Since then, she avoids cephalosporins. Tolerates penicillins.  She also c/o vomiting after taking Codeine in the past w/o any other sx.   *Neg hx of Covid - 19 infection
Potential expired dose given; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Potential expired dose given) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Potential expired dose given). On 02-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Potential expired dose given) had resolved.            No concomitant medications were reported. No treatment medications were reported.
Bilateral breast tenderness; Lump in her armpit; This spontaneous case was reported by a consumer and describes the occurrence of BREAST TENDERNESS (Bilateral breast tenderness) and AXILLARY MASS (Lump in her armpit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST TENDERNESS (Bilateral breast tenderness) and AXILLARY MASS (Lump in her armpit). At the time of the report, BREAST TENDERNESS (Bilateral breast tenderness) and AXILLARY MASS (Lump in her armpit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were reported.
Temp of 101; Chills; Body aches; This is a spontaneous report from a contactable consumer (patient). This patient of unspecified age and gender received the second dose of BNT162B2 (TRADE NAME UNSPECIFIED; lot number unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (lot number unknown) on an unspecified date for COVID-19 immunisation. On an unspecified date, one day after the second dose of the COVID-19 vaccine, the patient experienced a temperature of 101, chills, and body aches. The clinical outcomes of temperature 101, chills and body aches were resolved on unspecified dates soon thereafter.  Follow-up attempts are completed. No further information is expected; information about the lot number cannot be obtained.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 17-MAR-2014 the patient was vaccinated with expired, unspecified dose of VARIVAX (lot # 0568AE, expiration date: 15-MAR-2014). No adverse events were reported. Additional information is not expected.
Patient tested positive on 03/15/2021 Hospitalized on 03/16/2021
This spontaneous report was received from a doctor of pharmacy refers to a 81 year old female patient with no drug reactions/allergies. Current conditions included high blood pressure. On 09-JUL-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date not reported), subcutaneously. On 16-JUL-2013 (one week after patient received ZOSTAVAX), the patient experienced dizziness and "passed out", resulting in a minor accident. It was unspecified if patient was taken to a hospital. Pharmacist reported that patients doctor ruled out cardiovascular and neurological events such as stroke and "TIA's" by the completing of an echocardiogram (ECHO) and electrocardiogram (ECG). Pharmacist noted that patient had a recent change in her blood pressure medication but did not know specifics. The patient recovered on an unspecified date in 2013. The patient sought medical attention. Treatment information was unspecified. Causality was not reported. Additional information has been requested.
On day after administered, developed a 5 cm diameter hard lump at injection site, also redness edema redness, edema, & itching spread over a 1 week period to include arm from elbow to armpit. Symptoms gradually disappeared over 10 day period.
3RD after given dT booster, pt's arm began to swell in entire arm of injection site. (left arm. Pt felt fever, nausea with abdominal pain. and about 3 days duration. Now, 11 days later pt has erythema at injection site.
sick; Initial information received on 05-Oct-2021 regarding an unsolicited valid Social Media non-serious case from a consumer/non-healthcare professional via social media.  This case involves a patient (unknown age and gender) who was sick (illness), after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient's medical treatment(s), vaccination(s). concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick (illness) [unknown latency] following the administration of vaccine.  It was reported "No thanks! The last two that I had made me sick when I was perfectly healthy until the shot! I also hear that they are sneaking the covid vaccine in it!"  It was unknown if the patient experienced any additional symptoms/events.  There were no laboratory data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.
THE MODERNA BIVALENT VACCINE WAS OUT OF TEMPERATURE RANGE WHEN GIVEN TO PATIENT. PATIENT DID NOT SHOW ANY ADVERSE SIGN OR REACTIONS. ERROR WAS FOUND AFTER PATIENT HAD LEFT THE PHARMACY. PATIENT DID RETURN AN HOUR LATER TO RECEIVE ANOTHER MODERNA VACCINE WHICH WAS IN THE CORRECT TEMPERATURE RANGE.
pt recvd vax & 7 days p/vax pt exp sudden infant death synd; reporting MD indicated that pt also recvd DTP/HIB @ the same time as the 3rd dose of Engerix-B:
Patient developed cough, sneezing, shortness of breath, rhinorrhea and bilateral erythema of the eyes within a few minutes after receiving his vaccinations. He was immediately sent down to the ED where he received Epinephrine, Benadryl, Solumedrol and Famotidine with complete resolution of symptoms. 2/10/06 - Review of d/c summary indicates diagnosis was anaphylactic reaction. Symptoms were coughing, sneezing, rhinorrhea, red eyes, shortness of breath, and chest pain within minutes of receiving vaccines. 2/10/06 - Review of medical records confirms all of the above, adds wheezing and tachycardia to symptom list, and notes an allergy to Amoxil.
6/25/04: Broke out on face 6/23/04-evening. Rash had gone to chest and back by morning. Temp 103 cooled with bath and Tylenol. Temp broke and didn't go back up. Still has rash but no longer acting ill. 6/29/04 p/c to mom rash gone. Child feeling fine. 7/2/04 High temp last night. Broke out in pimples- mom thought may be chicken pox. Brought child in went to car to see him. 10/15 spots on chest 6-8 on head, not raised. Bites? Child vomited. High temp eyes glassy. Ref to PMD. Mom will take him in.
Since date of vaccine arm/shoulder was sore. Now one month later has increased pain and decreased range of motion, nocturnal pain.  12/02/09 OB progress notes for DOS 12/01/09 DX: L shoulder pain  Pt c/o arm and shoulder sore, increasing pain and decreased ROM, nocturnal pain.  On examination: ROM decreased, strength wnl, pulses intact. Orthopedic follow up.  12/28/09 Orthopedic consult notes received for DOS 12/23/09. DX: L shoulder pain and weakness. Pt c/o L shoulder pain after vaccination. Pt experienced stiffness, pain, difficulty bringing the arm overhead.  Upon examination: Pt able to move hand and elbows normally, overhead motion significantly diminished, able to flex to about 45 degrees and abduct 30 degrees, weak external rotation. Physician considered this event as inflammation of the bursa and rotator cuff tendons.  Tx: methylprednisolone injection, Marcaine.  Pt tolerated injection well.  Pt scheduled for a follow up appointment.
Severe muscle spasms size of walnut knot, by the shoulder and injection site/ feels like a cramp in is the leg be going on for 3-5 days; pain when taking a deep breath; numbness on leg and arm; feels like he is having a heart attack and feel like squeezing; Back pain , was extreme pain; felt tired and relaxed with first dose; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Severe muscle spasms size of walnut knot, by the shoulder and injection site/ feels like a cramp in is the leg be going on for 3-5 days), DYSPNOEA (pain when taking a deep breath), HYPOAESTHESIA (numbness on leg and arm), CHEST DISCOMFORT (feels like he is having a heart attack and feel like squeezing) and BACK PAIN (Back pain , was extreme pain) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer and Diabetes.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MUSCLE SPASMS (Severe muscle spasms size of walnut knot, by the shoulder and injection site/ feels like a cramp in is the leg be going on for 3-5 days), DYSPNOEA (pain when taking a deep breath), HYPOAESTHESIA (numbness on leg and arm), CHEST DISCOMFORT (feels like he is having a heart attack and feel like squeezing), BACK PAIN (Back pain , was extreme pain) and FATIGUE (felt tired and relaxed with first dose). In March 2021, MUSCLE SPASMS (Severe muscle spasms size of walnut knot, by the shoulder and injection site/ feels like a cramp in is the leg be going on for 3-5 days), DYSPNOEA (pain when taking a deep breath), HYPOAESTHESIA (numbness on leg and arm), CHEST DISCOMFORT (feels like he is having a heart attack and feel like squeezing), BACK PAIN (Back pain , was extreme pain) and FATIGUE (felt tired and relaxed with first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment information not provided.        Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2021: Follow-up received on 17-Apr-2021 contains significant information including lot number, location, updated medical conditions, new event was added and outcome of all event were updated from unknown to resolved. On 18-Jun-2021: Follow up received on 18-Apr-2021 contains no new information.
Extreme dizziness; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the arm left on 24Apr2021 at 18:30 as a single dose(at the age of 24-years-old) for COVID-19 immunisation. Concomitant medications included cholecalciferol (VITAMIN D3) from unknown date for unknown indication, magnesium supplement (MANUFACURER UNKNOWN) from unknown date for unknown indication and multivitamin (MANUFACURER UNKNOWN) from unknown date for unknown indication. The patient previously took cefdinir. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 06:00, the patient experienced extreme dizziness. Therapeutic measures taken were not reported. The clinical outcome of the event extreme dizziness was not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
The patient called the pharmacy to report that the evening after her first shingrix shot she started to feel her heart racing a lot more than normal, and then she was feverish throughout the night. In the morning she still didn't feel good and ended up blacking out and falling over. She notified the pharmacy on the Monday after and said she is feeling fine now.  She has called her primary physician and on of her specialist MDs in order to determine if she should be seen as well as to find out if she should get the second dose.
Patient seen on 10/12/15 for painful rash on chest and back for about 1 week. Diagnosed with shingles and prescribed Acyclovir 800 mg. One 4x day for 10 days and Ibuprofen 800 mg.
Narrative:  He presents now with onset nearly 12 hours ago of bandlike, somewhat colicky right upper quadrant discomfort associated with nonbilious nonbloody emesis, but no significant fevers chills sweats chest pain shortness of breath or change in his bowel movements. There's been no urinary symptoms. The pain initially went away just after midnight but then returned early this morning prompting his visit here in the emergency department. He was drove to the hospital by his wife. He has a hard time characterizing the pain, and finding a comfortable position. No history of urolithiasis. The patient denies any recent trauma or travel outside the country. The patient received his Covid vaccine 5 days ago, and his concern, in context of his history of Guillain-Barre, if this is due to an autoimmune flare? The symptoms started approximately 24 hours after receiving his vaccine and are very similar to his prior autonomic dysfunction. He denies any new neurological symptoms. May 13, 2021: #Ileus #Opioid induced constipation Presented with acute onset abdominal pain and radiographic imaging consistent with ileus. Differential primarily between opiate-induced ileus vs recurrence of his sensory-variant Guillain-Barre. LP completed 5/9 did not show any evidence of lymphocytosis or elevated protein making a GBS flare less likely.
sick for 24 hours; Initial information received on 09-Dec-2020 regarding an unsolicited valid non-serious social media case received from a consumer (patient).  This case involves a patient of unknown demographics who became sick for 24 hours (Illness), after receiving INFLUENZA VACCINE.  Relevant medical history, concomitant medications, past medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route on an unknown administration site.   On an unknown date, the patient became sick (Illness) (latency reported as within a week) (non serious event) following the administration of INFLUENZA VACCINE.  It was reported as patient received free Flu shot at work for 3 years and stopped taking it after that and never got sick from the 24 hour flu bug again.  Relevant laboratory test was not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the patient recovered from the event (reported as sick for 24 hours).  There would be no information available on batch number for this case.
aching, numbness, weakness tightness in chest, labored breathing, 23 days p/vax;hospitalized ICU-8 days requiring feeding tube;hosp 25 days walking w/aid of cain & receiving physiotherapy;
7 month old male was administered Varicella vaccine and MMR vaccine as part of an accelerated vaccination schedule; none of the patients developed symptoms of vaccine related viral illness;   This literature marketed report has been received from the authors of the published article, titled as stated above concerning a 7 month old male patient. The patient's concurrent conditions included biliary atresia. His pertinent medical history included failed Kasai procedure. Information regarding the patient's concomitant therapies were not provided by the authors.   On an unspecified date, as part of an accelerated vaccination schedule, the patient received a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) and a dose of varicella virus vaccine live (oka/merck) (manufacturer unknown) both administered for prophylaxis (strength, dose, frequency, route of administration lot number and expiration date were not provided). The patient received these vaccine doses 21 days prior a schedule orthotopic heart transplantation. The patient did not develop symptoms of vaccine related viral illness.   This is one of several reports received from the same literature article   A copy of the published article is attached as further documentation of the patient's experience.; Sender's Comments:  US-009507513-2107USA002514:
Solid lump at injection site with smaller bumps around it, itchiness, soreness in entire upper right arm
COVID vaccine, removed from freezer 12-17-21 at 930am, administered to patient on 1-17-2022 after 930am.
Stiffness of the arm of the injection; Fever; Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Stiffness of the arm of the injection), PYREXIA (Fever), PAIN (Body ache) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Stiffness of the arm of the injection), PYREXIA (Fever), PAIN (Body ache) and HEADACHE (Headache). The patient was treated with TRAMADOL at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Stiffness of the arm of the injection), PYREXIA (Fever), PAIN (Body ache) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
LARGE RED, HOT INDURATED AREA TO LT UPPER THIGH 60mm x 50mm
Patient received influenza, MENACTRA and PNEUMOVAX 'immunization' 10/28/13. The following day, she developed cellulitis after fever, (L) arm swelling noted. Cxs (-). Given antibiotics IV with subsidence of symptoms.
After sitting in waiting room at 10:00, at 10:03 a.m. began to feel strange with a sort of coldness and dizziness. Woke up on the floor with nurses around. Was told by nurses, I was convulsing  and was placed on the floor by nurse. After several minutes paramedics arrived and checked all vitals and blood pressure.
Hands and feet were burning, very painful and felt locked up. By the end of the day the extreme pain had subsided but now, hands, feet, ankles, back and arms hurt. So much so it?s keeping me up at night. Prior to the shot I did have hand pain due to RA. But not like this. Shooting pains start from wrists and go down into palms. Those come and go. Mornings are terrible. The pain is getting worse. Taking over the counter pain pills reduces the pain a little bit.
Patient had the vaccine and was doing well for 13 minutes then became nauseous and had feelings of throwing up.  patient then fainted briefly but regained consciousness after 30 seconds.  Was laying down on floor for 10 mins and was clammy, sweating and low blood pressure 116/68 but high pulse 90.  Patient states was very anxious after with frequent respirations.  Patient then was helped up to the chair and sat for 1 hour with blood pressure taken every 15 minutes.  Blood pressure was taken before leaving 128/71 before leaving attended by caregiver.   Patient states didn't eat and was working outside for 2 hours before getting vaccine.  Patient was advised to seek medical attention if condition worsened and was amendable to that suggestion.
Left hand ring finger and pinky swelling, bruising on pinky finger noted 7pm EST 4/8.  Administered 75mg Benadryl liquid, applied ice that evening 4/8, Administered 20mg loratidine and 1000mg Tylenol 4/9 am.  Swelling resolved by 4/10, bruising resolved by 4/11. Restless leg 4/8 at bedtime.  Left knee pain 4/9.
fatigue after his Covid Vaccinations; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue after his Covid Vaccinations) in an adult male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   In 2020, the patient RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) dosage was changed to 150 milligram once a day. On 14-Mar-2022, RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) dosage was changed to 150 milligram once a day. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 150 milligram once a day. On an unknown date, the patient experienced FATIGUE (fatigue after his Covid Vaccinations). At the time of the report, FATIGUE (fatigue after his Covid Vaccinations) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Concomitant medications were not reported.  No treatment information was provided by the reporter. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Pt experienced erythematous papular, pustular rash, diffuse over face, trunk, arms, legs, groin and soles of feet.
Patient hospitalized for Schizoaffective disorder, bipolar type within 6 weeks of receiving covid vaccination.
This spontaneous report as received from Registered Nurse refers to a female patient of unknown age. An unspecified female patient was administered the first dose in the GARDASIL vaccination series (dose and lot # was not reported) intramuscularly "in 2009" and subsequently was administered the second dose in the GARDASIL vaccination series (dose and lot # was not reported) intramuscularly on 25-JUL-2013. No adverse effect reported. Additional information has been requested.
fever up to 102.5, chills, severe general malaise, h/a, swelling & erythema & pain on  inj site;general sx lasted 2 days;local sx lasted 5-6days;